Floatz logo

Pioglitazone

Androgen Deficiency

State University of New York at BuffaloSmall moleculePhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

17 Active assets in the Androgen Deficiency cohort.

Asset / SponsorPhaseRating
TESTOSTERONE UNDECYLATE
Royal College of Surgeons, Ireland
Phase 3BB
Carboplatin
University of Washington
Phase 2BB
PREDNISONE TABLETS
SWOG Cancer Research Network
Phase 3BB
Abiraterone Acetate
SWOG Cancer Research Network
Phase 3BB
Docetaxel
SWOG Cancer Research Network
Phase 3BB

View all 36 →

Same molecule, other indications

Pioglitazone is also rated in:

diabetes mellitusDormant
BBB
Indicative ·
79 / 100
View asset →
metabolic dysfunction-associated steatohepatitisDormant
BBB
Indicative ·
75 / 100
View asset →
abdominal obesity-metabolic syndromeDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →